Comparing Prediction Tools

European Urology

Volumn 57, Issue 4, 2010, Pages 569-570

  Kattan, Michael W ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; CALIBRATION; CANCER GROWTH; CANCER OF THE PROSTATE RISK ASSESSMENT SCORE; CLINICAL DECISION MAKING; COMPARATIVE STUDY; EDITORIAL; HUMAN; LYMPH NODE METASTASIS; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SCORING SYSTEM; TREATMENT OUTCOME;

AGE FACTORS; BIOPSY; DECISION SUPPORT TECHNIQUES; DISEASE-FREE SURVIVAL; HUMANS; MALE; MODELS, STATISTICAL; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77249099794     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.01.006     Document Type: Editorial

References (13)

1. Lughezzani G., Budäus L., Isbarn H., et al. Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy. Eur Urol 57 (2010) 562-568
2. Stephenson A., Scardino P., Eastham J., et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 98 (2006) 715-717
3. Cooperberg M., Pasta D., Elkin E., et al. The University of California San Francisco cancer of the prostate risk assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 173 (2005) 1938-1942
4. D'Amico A.V., Whittington R., Malkowicz B.S., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
5. Harrell Jr. F.E., Califf R.M., Pryor D.B., Lee K.L., and Rosati R.A. Evaluating the yield of medical tests. JAMA 247 (1982) 2543-2546
6. Steyerberg E., Vickers A., Cook N., et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21 (2010) 128-138
7. Vickers A., and Elkin E. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26 (2006) 565-574
8. Kattan M.W., Cowen M.E., and Miles B.J. A decision analysis for treatment of clinically localized prostate cancer. J Gen Intern Med. 12 (1997) 299-305
9. Kattan M. Comparative effectiveness: a table of expected benefits and harms. Med Decis Making 29 (2009) NP3-5
10. Nguyen C., and Kattan M. Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling. Cancer 115 Suppl (2009) 3039-3045
11. Stephenson A., Kattan M., Eastham J., et al. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 24 (2006) 3973-3978
12. Ross P.L., Gerigk C., Gonen M., et al. Comparisons of nomograms and urologists' predictions in prostate cancer. Semin Urol Oncol 20 (2002) 82-88
13. Specht M., Kattan M., Gonen M., Fey J., and Van Zee K. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 12 (2005) 654-659